Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

The supplement gummy and serum safely improve hair growth in women with hair loss.

Caragana korshinskii seed oil effectively treats fungal skin infections.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

Fungal skin infections significantly lower patients' quality of life.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Treatments with sunscreen and active ingredients can reduce skin hyperpigmentation by decreasing DNA methylation.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Eflornithine HCl 13.9% cream is safe for skin use with mild, temporary irritation.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

The treatment was effective for the puppy's skin and intestinal infections.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

PRP therapy is effective and safe for various skin and hair conditions.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.